Transpire Bio Strengthens Leadership Team with New Appointments to Lead Commercialization, Quality Assurance, and Manufacturing Read News Article »
Transpire Bio Achieves Important Corporate Milestone with Dosing of First Human Subject in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program Read News Article »
Transpire Bio Expands Access and Innovation in Inhalation Therapies with New Research and Manufacturing Facility Read News Article »
Transpire Bio announces agreement with INTO for the development of three inhaled medicines Read News Article »
Transpire Bio Strengthens Its Leadership Team with a New Senior-Level Appointment Read News Article »
Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine Read News Article »
